Abstract
Thyroid disease in pregnant women needs attention from a clinical and scientific standpoint due to the potential severe adverse consequences. It is well-established that overt thyroid disease in pregnant women should be treated to prevent maternal and fetal complications, but routine testing for overt thyroid function test abnormalities has not been implemented. In contrast, the scientific focus has shifted towards smaller aberrations in maternal thyroid function including subclinical thyroid disease and isolated deviations in maternal thyroxine. In this focused review, we touch upon the assessment of maternal thyroid function in pregnancy and how the historical advancements in thyroid function tests parallel with the thyroid function test abnormalities described. Furthermore, we discuss how the scientific focus has evolved and how the field could turn in view of the existing discrepancies between results of observational studies and randomized controlled trials.
References
1.
Choufoer
JC
, Vanrhijn
M
, Querido
A
. Endemic goiter in Western New Guinea. II. Clinical picture, incidence and pathogenesis of endemic cretinism
. J Clin Endocrinol Metab
. 1965
Mar
;25
(3
):385
–402
.
[PubMed]
0021-972X2.
Pharoah
PO
, Buttfield
IH
, Hetzel
BS
. Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy
. Lancet
. 1971
Feb
;1
(7694
):308
–10
.
[PubMed]
0140-67363.
Grüters
A
, Krude
H
. Detection and treatment of congenital hypothyroidism
. Nat Rev Endocrinol
. 2011
Oct
;8
(2
):104
–13
.
[PubMed]
1759-50294.
Vulsma
T
, Gons
MH
, de Vijlder
JJ
. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis
. N Engl J Med
. 1989
Jul
;321
(1
):13
–6
.
[PubMed]
0028-47935.
Lazarus
J
, Brown
RS
, Daumerie
C
, Hubalewska-Dydejczyk
A
, Negro
R
, Vaidya
B
. 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children
. Eur Thyroid J
. 2014
Jun
;3
(2
):76
–94
.
[PubMed]
2235-06406.
Alexander
EK
, Pearce
EN
, Brent
GA
, Brown
RS
, Chen
H
, Dosiou
C
, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
. Thyroid
. 2017
Mar
;27
(3
):315
–89
.
[PubMed]
1050-72567.
Cooper
DS
, Anton
B
. The Decade in Clinical Thyroid Disease: An Analysis of Published Literature
. Thyroid
. 2016
Aug
;26
(8
):993
–1003
.
[PubMed]
1050-72568.
Spencer
C
. Thyroid function tests: Assay of thyroid hormones and related substances [cited 2019 Dec 12]. Available from: www.thyroidmanager.com9.
Kuyl
JM
. The evolution of thyroid function tests
. J Endocrinol Metab Diabetes South Africa.
2015
;20
(2
):11
–6
.10.
Andersen
S
, Bruun
NH
, Pedersen
KM
, Laurberg
P
. Biologic variation is important for interpretation of thyroid function tests
. Thyroid
. 2003
Nov
;13
(11
):1069
–78
.
[PubMed]
1050-725611.
Boas
M
, Forman
JL
, Juul
A
, Feldt-Rasmussen
U
, Skakkebaek
NE
, Hilsted
L
, et al. Narrow intra-individual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 women
. Eur J Endocrinol
. 2009
Dec
;161
(6
):903
–10
.
[PubMed]
0804-464312.
Laurberg
P
, Andersen
SL
, Hindersson
P
, Nohr
EA
, Olsen
J
. Dynamics and Predictors of Serum TSH and fT4 Reference Limits in Early Pregnancy: A Study Within the Danish National Birth Cohort
. J Clin Endocrinol Metab
. 2016
Jun
;101
(6
):2484
–92
.
[PubMed]
0021-972X13.
Andersen
SL
, Andersen
S
, Carlé
A
, Christensen
PA
, Handberg
A
, Karmisholt
J
, et al. Pregnancy Week-Specific Reference Ranges for Thyrotropin and Free Thyroxine in the North Denmark Region Pregnancy Cohort
. Thyroid
. 2019
Mar
;29
(3
):430
–8
.
[PubMed]
1050-725614.
Feldt-Rasmussen
U
, Bliddal
S
, Rasmussen
AK
, Boas
M
, Hilsted
L
, Main
K
. Challenges in interpretation of thyroid function tests in pregnant women with autoimmune thyroid disease
. J Thyroid Res
. 2011
Mar
;2011
(Mar
):598712
.
[PubMed]
2042-007215.
Laurberg
P
, Andersen
SL
. ENDOCRINOLOGY IN PREGNANCY: pregnancy and the incidence, diagnosing and therapy of Graves’ disease
. Eur J Endocrinol
. 2016
Nov
;175
(5
):R219
–30
.
[PubMed]
0804-464316.
Lee
RH
, Spencer
CA
, Mestman
JH
, Miller
EA
, Petrovic
I
, Braverman
LE
, et al. Free T4 immunoassays are flawed during pregnancy
. Am J Obstet Gynecol
. 2009
Mar
;200
(3
):260.e1
–6
.
[PubMed]
0002-937817.
Anckaert
E
, Poppe
K
, Van Uytfanghe
K
, Schiettecatte
J
, Foulon
W
, Thienpont
LM
. FT4 immunoassays may display a pattern during pregnancy similar to the equilibrium dialysis ID-LC/tandem MS candidate reference measurement procedure in spite of susceptibility towards binding protein alterations
. Clin Chim Acta
. 2010
Sep
;411
(17-18
):1348
–53
.
[PubMed]
0009-898118.
Bliddal
S
, Feldt-Rasmussen
U
, Boas
M
, Faber
J
, Juul
A
, Larsen
T
, et al. Gestational age-specific reference ranges from different laboratories misclassify pregnant women’s thyroid status: comparison of two longitudinal prospective cohort studies
. Eur J Endocrinol
. 2013
Dec
;170
(2
):329
–39
.
[PubMed]
0804-464319.
Korevaar
TI
, Chaker
L
, Medici
M
, de Rijke
YB
, Jaddoe
VW
, Steegers
EA
, et al. Maternal total T4 during the first half of pregnancy: physiologic aspects and the risk of adverse outcomes in comparison with free T4
. Clin Endocrinol (Oxf)
. 2016
Nov
;85
(5
):757
–63
.
[PubMed]
0300-066420.
Andersen
SL
, Olsen
J
, Laurberg
P
. Foetal programming by maternal thyroid disease
. Clin Endocrinol (Oxf)
. 2015
Dec
;83
(6
):751
–8
.
[PubMed]
0300-066421.
Andersen
SL
, Carlé
A
, Karmisholt
J
, Pedersen
IB
, Andersen
S
. MECHANISMS IN ENDOCRINOLOGY: Neurodevelopmental disorders in children born to mothers with thyroid dysfunction: evidence of fetal programming?
Eur J Endocrinol
. 2017
Jul
;177
(1
):R27
–36
.
[PubMed]
0804-464322.
Laurberg
P
, Andersen
SL
, Pedersen
IB
, Andersen
S
, Carlé
A
. Screening for overt thyroid disease in early pregnancy may be preferable to searching for small aberrations in thyroid function tests
. Clin Endocrinol (Oxf)
. 2013
Sep
;79
(3
):297
–304
.
[PubMed]
0300-066423.
Haddow
JE
, Palomaki
GE
, Allan
WC
, Williams
JR
, Knight
GJ
, Gagnon
J
, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child
. N Engl J Med
. 1999
Aug
;341
(8
):549
–55
.
[PubMed]
0028-479324.
Andersen
SL
, Andersen
S
, Liew
Z
, Vestergaard
P
, Olsen
J
. Maternal thyroid function in early pregnancy and neuropsychological performance of the child at 5 years of age
. J Clin Endocrinol Metab
. 2018
Feb
;103
(2
):660
–70
.
[PubMed]
0021-972X25.
Bava
S
, Ballantyne
AO
, Trauner
DA
. Disparity of verbal and performance IQ following early bilateral brain damage
. Cogn Behav Neurol
. 2005
Sep
;18
(3
):163
–70
.
[PubMed]
1543-363326.
Gläscher
J
, Tranel
D
, Paul
LK
, Rudrauf
D
, Rorden
C
, Hornaday
A
, et al. Lesion mapping of cognitive abilities linked to intelligence
. Neuron
. 2009
Mar
;61
(5
):681
–91
.
[PubMed]
0896-627327.
Jansen
TA
, Korevaar
TIM
, Mulder
TA
, White
T
, Muetzel
RL
, Peeters
RP
, et al. Maternal thyroid function during pregnancy and child brain morphology: a time window-specific analysis of a prospective cohort. lancet Diabetes Endocrinol. 2019
Aug;7(8):629–37.28.
Cooper
DS
, Biondi
B
. Subclinical thyroid disease
. Lancet
. 2012
Mar
;379
(9821
):1142
–54
.
[PubMed]
0140-673629.
Fraenkel
M
, Shafat
T
, Cahn
A
, Erez
O
, Novack
V
, Tsur
A
. Low thyroid-stimulating hormone and its persistence beyond the first trimester of pregnancy
. Int J Gynaecol Obstet
. 2018
Sep
;142
(3
):270
–6
.
[PubMed]
0020-729230.
Fan
J
, Zhang
Y
, Zhang
C
, Barjaktarovic
M
, Yang
X
, Peeters
RP
, et al. Persistency of Thyroid Dysfunction from Early to Late Pregnancy
. Thyroid
. 2019
Oct
;29
(10
):1475
–84
.
[PubMed]
1050-725631.
Andersen
SL
, Olsen
J
. Early Pregnancy Thyroid Function Test Abnormalities in Biobank Sera from Women Clinically Diagnosed with Thyroid Dysfunction Before or After Pregnancy
. Thyroid
. 2017
Mar
;27
(3
):451
–9
.
[PubMed]
1050-725632.
Knøsgaard
L
, Andersen
S
, Hansen
AB
, Vestergaard
P
, Andersen
SL
. Thyroid function abnormalities and thyroid autoantibodies in Danish pregnant women
. Clin Endocrinol (Oxf)
. 2019
Dec
;
[PubMed]
1365-226533.
Selmer
C
, Faber
J.
Editorial commentary: Subclinical thyroid dysfunction and cardiovascular risk: Nothing to lose, everything to gain? Trends Cardiovasc Med. 2019
May;1050-1738(19):30067–2.34.
Casey
BM
, Dashe
JS
, Wells
CE
, McIntire
DD
, Leveno
KJ
, Cunningham
FG
. Subclinical hyperthyroidism and pregnancy outcomes
. Obstet Gynecol
. 2006
Feb
;107
(2 Pt 1
):337
–41
.
[PubMed]
0029-784435.
Korevaar
TI
, Derakhshan
A
, Taylor
PN
, Meima
M
, Chen
L
, Bliddal
S
, et al.; Consortium on Thyroid and Pregnancy—Study Group on Preterm Birth
. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis
. JAMA
. 2019
Aug
;322
(7
):632
–41
.
[PubMed]
0098-748436.
Negro
R
, Formoso
G
, Mangieri
T
, Pezzarossa
A
, Dazzi
D
, Hassan
H
. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications
. J Clin Endocrinol Metab
. 2006
Jul
;91
(7
):2587
–91
.
[PubMed]
0021-972X37.
Negro
R
, Schwartz
A
, Gismondi
R
, Tinelli
A
, Mangieri
T
, Stagnaro-Green
A
. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy
. J Clin Endocrinol Metab
. 2010
Apr
;95
(4
):1699
–707
.
[PubMed]
0021-972X38.
Nazarpour
S
, Ramezani Tehrani
F
, Simbar
M
, Tohidi
M
, Alavi Majd
H
, Azizi
F
. Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease
. Eur J Endocrinol
. 2017
Feb
;176
(2
):253
–65
.
[PubMed]
0804-464339.
Lazarus
JH
, Bestwick
JP
, Channon
S
, Paradice
R
, Maina
A
, Rees
R
, et al. Antenatal thyroid screening and childhood cognitive function
. N Engl J Med
. 2012
Feb
;366
(6
):493
–501
.
[PubMed]
0028-479340.
Casey
BM
, Thom
EA
, Peaceman
AM
, Varner
MW
, Sorokin
Y
, Hirtz
DG
, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network
. Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy
. N Engl J Med
. 2017
Mar
;376
(9
):815
–25
.
[PubMed]
0028-479341.
Wang
H
, Gao
H
, Chi
H
, Zeng
L
, Xiao
W
, Wang
Y
, et al. Effect of Levothyroxine on Miscarriage Among Women With Normal Thyroid Function and Thyroid Autoimmunity Undergoing In Vitro Fertilization and Embryo Transfer: A Randomized Clinical Trial
. JAMA
. 2017
Dec
;318
(22
):2190
–8
.
[PubMed]
0098-748442.
Nazarpour
S
, Ramezani Tehrani
F
, Simbar
M
, Tohidi
M
, Minooee
S
, Rahmati
M
, et al. Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism, Negative for Thyroid Peroxidase Antibodies
. J Clin Endocrinol Metab
. 2018
Mar
;103
(3
):926
–35
.
[PubMed]
0021-972X43.
Dhillon-Smith
RK
, Middleton
LJ
, Sunner
KK
, Cheed
V
, Baker
K
, Farrell-Carver
S
, et al. Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception
. N Engl J Med
. 2019
Apr
;380
(14
):1316
–25
.
[PubMed]
0028-479344.
Brent
GA
. The debate over thyroid-function screening in pregnancy
. N Engl J Med
. 2012
Feb
;366
(6
):562
–3
.
[PubMed]
0028-479345.
Cooper
DS
, Pearce
EN
. Subclinical Hypothyroidism and Hypothyroxinemia in Pregnancy - Still No Answers
. N Engl J Med
. 2017
Mar
;376
(9
):876
–7
.
[PubMed]
0028-479346.
Hales
C
, Taylor
PN
, Channon
S
, Paradice
R
, McEwan
K
, Zhang
L
, et al. Controlled Antenatal Thyroid Screening II: effect of treating maternal sub-optimal thyroid function on child cognition
. J Clin Endocrinol Metab
. 2018
Apr
;103
(4
):1583
–91
.
[PubMed]
0021-972X47.
Hales
C
, Taylor
PN
, Channon
S
, McEwan
K
, Thapar
A
, Langley
K
, et al. Controlled Antenatal Thyroid Screening II: effect of treating maternal sub-optimal thyroid function on child behaviour
. J Clin Endocrinol Metab
. 2019
Oct
;dgz098
.
[PubMed]
0021-972X48.
Maraka
S
, Mwangi
R
, McCoy
RG
, Yao
X
, Sangaralingham
LR
, Singh Ospina
NM
, et al. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment
. BMJ
. 2017
Jan
;356
:i6865
.
[PubMed]
0959-813849.
Man
EB
. Thyroid function in pregnancy and infancy. Maternal hypothyroxinemia and retardation of progeny
. CRC Crit Rev Clin Lab Sci
. 1972
Jun
;3
(2
):203
–25
.
[PubMed]
0590-819150.
Sinha
AK
, Pickard
MR
, Ekins
RP
. Maternal hypothyroxinemia and brain development: I. A hypothetical control system governing fetal exposure to maternal thyroid hormones
. Acta Med Austriaca
. 1992
;19
Suppl 1
:40
–8
.
[PubMed]
0303-817351.
Glinoer
D
, Delange
F
. The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny
. Thyroid
. 2000
Oct
;10
(10
):871
–87
.
[PubMed]
1050-725652.
Morreale de Escobar
G
, Obregón
MJ
, Escobar del Rey
F
. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia?
J Clin Endocrinol Metab
. 2000
Nov
;85
(11
):3975
–87
.
[PubMed]
0021-972X53.
Morreale de Escobar
G
. Maternal hypothyroxinemia versus hypothyroidism and potential neurodevelopmental. Alterations of her offspring
. Ann Endocrinol (Paris)
. 2003
Feb
;64
(1
):51
–2
.
[PubMed]
0003-426654.
Román
GC
. Autism: transient in utero hypothyroxinemia related to maternal flavonoid ingestion during pregnancy and to other environmental antithyroid agents
. J Neurol Sci
. 2007
Nov
;262
(1-2
):15
–26
.
[PubMed]
0022-510X55.
Negro
R
, Soldin
OP
, Obregon
MJ
, Stagnaro-Green
A
. Hypothyroxinemia and pregnancy
. Endocr Pract
. 2011
May-Jun
;17
(3
):422
–9
.
[PubMed]
1530-891X56.
Henrichs
J
, Ghassabian
A
, Peeters
RP
, Tiemeier
H
. Maternal hypothyroxinemia and effects on cognitive functioning in childhood: how and why?
Clin Endocrinol (Oxf)
. 2013
Aug
;79
(2
):152
–62
.
[PubMed]
0300-066457.
Furnica
RM
, Lazarus
JH
, Gruson
D
, Daumerie
C
. Update on a new controversy in endocrinology: isolated maternal hypothyroxinemia
. J Endocrinol Invest
. 2015
Feb
;38
(2
):117
–23
.
[PubMed]
0391-409758.
Chan
S
, Boelaert
K
. Optimal management of hypothyroidism, hypothyroxinaemia and euthyroid TPO antibody positivity preconception and in pregnancy
. Clin Endocrinol (Oxf)
. 2015
Mar
;82
(3
):313
–26
.
[PubMed]
0300-066459.
Lazarus
JH
, Taylor
PN
. Hypothyroxinaemia and brain development
. Acta Endocrinol (Bucur)
. 2016
Jan-Mar
;12
(1
):1
–6
.
[PubMed]
1841-098760.
Min
H
, Dong
J
, Wang
Y
, Wang
Y
, Teng
W
, Xi
Q
, et al. Maternal Hypothyroxinemia-Induced Neurodevelopmental Impairments in the Progeny
. Mol Neurobiol
. 2016
Apr
;53
(3
):1613
–24
.
[PubMed]
0893-764861.
Dosiou
C
, Medici
M
. MANAGEMENT OF ENDOCRINE DISEASE: Isolated maternal hypothyroxinemia during pregnancy: knowns and unknowns
. Eur J Endocrinol
. 2017
Jan
;176
(1
):R21
–38
.
[PubMed]
0804-464362.
Boyages
SC
, Halpern
JP
. Endemic cretinism: toward a unifying hypothesis
. Thyroid
. 1993
;3
(1
):59
–69
.
[PubMed]
1050-725663.
Pharoah
PO
, Connolly
KJ
, Ekins
RP
, Harding
AG
. Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children
. Clin Endocrinol (Oxf)
. 1984
Sep
;21
(3
):265
–70
.
[PubMed]
0300-066464.
Pop
VJ
, Kuijpens
JL
, van Baar
AL
, Verkerk
G
, van Son
MM
, de Vijlder
JJ
, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy
. Clin Endocrinol (Oxf)
. 1999
Feb
;50
(2
):149
–55
.
[PubMed]
0300-066465.
Aung
T
, Halsey
J
, Kromhout
D
, Gerstein
HC
, Marchioli
R
, Tavazzi
L
, et al. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. 2018
Mar;3(3):225–34.66.
Manson
JE
, Cook
NR
, Lee
IM
, Christen
W
, Bassuk
SS
, Mora
S
, et al.; VITAL Research Group
. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
. N Engl J Med
. 2019
Jan
;380
(1
):33
–44
.
[PubMed]
0028-479367.
Vandenbroucke
JP
, Merrall
EL
. The HRT controversy: observational studies and RCTs fall in line
. Lancet
. 2009
Apr
;373
(9671
):1233
–5
.
[PubMed]
0140-673668.
Jepsen
P
, Johnsen
SP
, Gillman
MW
, Sørensen
HT
. Interpretation of observational studies
. Heart
. 2004
Aug
;90
(8
):956
–60
.
[PubMed]
1355-603769.
Knight
BA
, Shields
BM
, Hattersley
AT
, Vaidya
B
. Maternal hypothyroxinaemia in pregnancy is associated with obesity and adverse maternal metabolic parameters
. Eur J Endocrinol
. 2016
Jan
;174
(1
):51
–7
.
[PubMed]
0804-464370.
Haddow
JE
, Craig
WY
, Neveux
LM
, Palomaki
GE
, Lambert-Messerlian
G
, Malone
FD
, et al.; First and Second Trimester Risk of Aneuploidy (FaSTER) Research Consortium
. Free Thyroxine During Early Pregnancy and Risk for Gestational Diabetes
. PLoS One
. 2016
Feb
;11
(2
):e0149065
.
[PubMed]
1932-620371.
Teng
X
, Shan
Z
, Li
C
, Yu
X
, Mao
J
, Wang
W
, et al. Iron Deficiency May Predict Greater Risk for Hypothyroxinemia: A Retrospective Cohort Study of Pregnant Women in China
. Thyroid
. 2018
Aug
;28
(8
):968
–75
.
[PubMed]
1050-725672.
Ellervik
C
, Roselli
C
, Christophersen
IE
, Alonso
A
, Pietzner
M
, Sitlani
CM
, et al. Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study
. JAMA Cardiol
. 2019
Feb
;4
(2
):144
–52
.
[PubMed]
2380-6583© 2020 European Thyroid Association Published by S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
